Triphuridet Natthaya, Nagasaka Misako, Shum Elaine, Ou Sai-Hong Ignatius
Department of Medicine, Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.
Division of Hematology-Oncology, Department of Medicine, University of California Irvine School of Medicine, Orange, CA, USA.
Transl Lung Cancer Res. 2024 May 31;13(5):1047-1060. doi: 10.21037/tlcr-23-816. Epub 2024 May 29.
We previously demonstrated in a meta-analysis there was no difference in risk ratio (RR) of lung cancer detected by low-dose computed tomography (LDCT) screening among female never-smokers (NS) and male ever-smokers (ES) in Asia. LDCT screening significantly decreased lung cancer death among Asian NS compared to Asian ES (RR =0.27, P<0.001).
We investigated if race, age at diagnosis, and histology further differentiate lung cancer diagnosed by LDCT among in NS and ES using the 14 studies from our previous meta-analysis.
Twelve publications reported relevant data utilized in this study. From five Asian and one international studies, Asian ES had similar risk of lung cancer diagnosed at baseline screening as Asian NS [RR =0.96; 95% confidence interval (CI): 0.74-1.24] but among non-Asian ES had a 4.56 times significantly higher risk than non-Asian NS (RR =4.56; 95% CI: 2.85-7.28). The baseline incidence of lung cancer in never-smoker (LCINS) was approximately 2.3 times higher among Asian NS than non-Asian NS (0.62% 0.27%, P=0.001). Asian ES had about half the baseline incidence of lung cancer diagnosed as non-Asian ES (0.65% 1.26%). LCINS was diagnosed at 1.98 years younger than ES (95% CI: -3.38 to -0.58) (four studies) and exhibited a higher proportion of adenocarcinoma (ADC) (96.58% 70.37%).
Among normal-risk individuals, LCINS had a significantly higher likelihood of being diagnosed among Asians than non-Asians, predominantly manifesting as ADC and diagnosed approximately 2 years younger than ES suggesting that the age limit to initiate lung cancer screening in NS may be set lower compared to LDCT lung cancer screening among ES.
我们之前在一项荟萃分析中表明,在亚洲,低剂量计算机断层扫描(LDCT)筛查检测出的肺癌风险比(RR)在女性从不吸烟者(NS)和男性曾经吸烟者(ES)之间没有差异。与亚洲曾经吸烟者相比,LDCT筛查显著降低了亚洲从不吸烟者的肺癌死亡率(RR = 0.27,P < 0.001)。
我们使用之前荟萃分析中的14项研究,调查种族、诊断时年龄和组织学是否能进一步区分从不吸烟者和曾经吸烟者中通过LDCT诊断的肺癌。
12篇出版物报告了本研究中使用的相关数据。在5项亚洲和1项国际研究中,亚洲曾经吸烟者在基线筛查时被诊断为肺癌的风险与亚洲从不吸烟者相似[RR = 0.96;95%置信区间(CI):0.74 - 1.24],但在非亚洲曾经吸烟者中,其风险比非亚洲从不吸烟者高4.56倍(RR = 4.56;95% CI:2.85 - 7.28)。亚洲从不吸烟者中肺癌的基线发病率(LCINS)比非亚洲从不吸烟者高约2.3倍(0.62%对0.27%,P = 0.001)。亚洲曾经吸烟者被诊断为肺癌的基线发病率约为非亚洲曾经吸烟者的一半(0.65%对1.26%)。从不吸烟者肺癌(LCINS)的诊断年龄比曾经吸烟者年轻1.98岁(95% CI:-3.38至-0.58)(4项研究),且腺癌(ADC)比例更高(96.58%对70.37%)。
在正常风险个体中,亚洲人被诊断为LCINS的可能性显著高于非亚洲人,主要表现为ADC,诊断年龄比曾经吸烟者小约2岁,这表明与曾经吸烟者的LDCT肺癌筛查相比,从不吸烟者开始肺癌筛查的年龄限制可能可以设定得更低。